BMS-984923
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BMS-984923, covering 2023-04-13 to 2025-02-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating the Potential of BMS-984923 to Alter the Systemic Exposure of Three Orally Administered Probe Substrates [Phase 1]